| Causes of hOCT1‐dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor‐selective gene therapy E Lozano, RIR Macias, MJ Monte, M Asensio, S Del Carmen, ... Hepatology 70 (4), 1246-1261, 2019 | 57 | 2019 |
| ACOX2 deficiency: an inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia MJ Monte, M Alonso-Peña, O Briz, E Herraez, C Berasain, J Argemi, ... Journal of hepatology 66 (3), 581-588, 2017 | 47 | 2017 |
| Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma M Alonso-Peña, A Sanchez-Martin, P Sanchon-Sanchez, M Soto-Muñiz, ... Cancer Drug Resistance 2 (3), 680, 2019 | 7 | 2019 |
| Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer M Alonso-Peña, RA Espinosa-Escudero, M Soto-Muñiz, ... Pharmacogenomics 20 (13), 957-970, 2019 | 1 | 2019 |
| Suppression of bile acid-CoA: amino acid N-acyltransferase gene expression by Oncostatin M M Alonso-Peña, A Geier, H Hermanns Zeitschrift für Gastroenterologie 58 (01), 3.29, 2020 | | 2020 |
| Genetic and pathophysiological factors leading to deficient acyl-CoA oxidase 2 (ACOX2) activity in hepatocytes, an alteration which causes oxidative and endoplasmic reticulum … M Alonso-Pena, H HERMANS, E Herraez, O Briz, MJ MONTE, ... Journal of Hepatology 70, E579-E579, 2019 | | 2019 |
| Suppression of bile acid-CoA: amino acid N-acyltransferase gene expression by the interleukin-6-type cytokine Oncostatin M M Alonso-Pena, A Geier, HM Hermanns Zeitschrift für Gastroenterologie 57 (01), P1. 1, 2019 | | 2019 |
| Resumen de tesis. Identificación de un nuevo defecto genético del metabolismo de los ácidos biliares: deficiencia de la enzima ACOX2. Bases moleculares, fisiopatología e … M Alonso Peña | | 2019 |
| The absence of OCT1 at the plasma membrane of tumor cells is associated with a worse response of hepatocellular carcinoma to sorafenib A Geier, R Al-Abdulla, R Macias, D Bettinger, J Weiss, H Bantel, D Jahn, ... Journal of Hepatology 1 (66), S230, 2017 | | 2017 |
| SENSIBILIZACIÓN DEL COLANGIOCARCINOMA A LA QUIMIOTERAPIA POR REPRESIÓN DE LAS BOMBAS EXPORTADORAS DE FÁRMACOS ABCC3 Y ABCG2 INDUCIDA POR LA SOBRE-EXPRESIÓN DE SOX17 E Lozano, M Asensio, O Briz, L Perez-Silva, E Herraez, MR Romero, ... | | |
